Regeneron Pharmaceuticals, Inc.

NY · United States · Reporting entity ID 100000000069

Total reported 2019–2025

$1.15B

#16 of 2,960 reporting companies — 1.4% of all reported industry payments

$51.0M in general payments across 24,746 records, plus $1.09B in research funding across 206,458 records.

How it breaks down

General payments $50,991,821

Research funding $1,094,125,708

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.